A Hexavalent Human Rotavirus–Bovine Rotavirus (UK) Reassortant Vaccine Designed for Use in Developing Countries and Delivered in a Schedule with the Potential to Eliminate the Risk of Intussusception

Authors :: Albert Z. Kapikian
John R. La Montagne
Timo Vesikari
Brian R. Murphy
Robert M. Chanock
David M. Morens
Lone Simonsen
Yasutaka Hoshino
Source :: The Journal of Infectious Diseases. 192:S22-S29
Publication Year :: 2005
Publisher :: Oxford University Press (OUP), 2005.
Abstract: There is an urgent need for a rotavirus vaccine, because up to 592,000 infants and young children

Tools